在风湿性疾病中慢性炎症和衰老
Zewen Wu1, Jingxuan Li1, Rong Li1
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi, China.
Aging and disease
|January 31, 2026
概括
细胞衰老和免疫衰老导致慢性炎症和组织损伤的类风湿性疾病,如骨关节炎和类风湿性关节炎. 针对这些衰老过程,使用诸如老化药物之类的疗法,为管理这些疾病提供了一种有希望的方法.
科学领域:
- 老年学是指老年学的学科.
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 细胞衰老和免疫衰老有助于慢性炎症和组织损伤.
- 与衰老相关的分泌表型 (SASP) 释放出促炎细胞因子 (IL-6,IL-1β,TNF-α).
- 在骨关节炎 (OA) 和类风湿性关节炎 (RA) 中,衰老细胞加剧了疾病病理.
研究的目的:
- 审查细胞衰老和免疫衰老在与年龄相关的类风湿性疾病中的作用.
- 讨论SASP介导炎症对OA和RA的影响.
- 突出针对衰老机制的新兴治疗策略.
主要方法:
- 在类风湿性疾病中对细胞衰老,免疫衰老和SASP的文献综述.
- 对促炎性细胞因子在OA和RA发病过程中的作用的分析.
- 评价 senolytics 和细胞因子抑制剂作为治疗干预措施.
主要成果:
- 衰老细胞和SASP驱动了类风湿性疾病中的慢性炎症.
- 在OA中,衰老的软骨细胞促进了软骨的退化.
- 在RA中,老化的免疫细胞会损害自我耐受性,使疾病恶化.
- 老化剂和细胞因子抑制剂在临床前研究中显示出潜力.
结论:
- 结合抗衰老和抗炎策略对于管理与年龄相关的类风湿性疾病至关重要.
- 针对细胞衰老和SASP提供了一个新的治疗途径.
- 对老化剂和细胞因子抑制剂的进一步研究对于OA和RA治疗是有必要的.
相关概念视频
01:23Rheumatic Heart Disease I: Introduction
520
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
520
01:20Rheumatic Heart Disease IV: Nursing Management
332
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
332
01:21Rheumatic Heart Disease III: Medical Management
358
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
358
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
589
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
589
01:38Inflammation
62.1K
Overview
62.1K
01:25Chronic Kidney Disease I: Introduction
736
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
736